# Sweet Wormwood (Artemisia annua)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/sweet-wormwood
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Traditional Chinese Medicine
**Also Known As:** Qinghao, Annual Wormwood, Sweet Annie, Annual Mugwort, Chinese Wormwood, Artemisia annua L., Qing Hao Su, Herba Artemisiae Annuae

## Overview

Sweet Wormwood (Artemisia annua) contains artemisinin as its primary bioactive sesquiterpene lactone, which exerts antimalarial and cytotoxic effects by generating [reactive oxygen species](/ingredients/condition/antioxidant) upon activation by heme iron inside parasitized red blood cells. The compound disrupts parasite [mitochondrial function](/ingredients/condition/energy) and induces apoptosis-like cell death in Plasmodium falciparum, making it the chemical backbone of WHO-recommended artemisinin-based combination therapies (ACTs).

## Health Benefits

• [Antioxidant](/ingredients/condition/antioxidant) properties: In vitro studies show concentration-dependent scavenging of hydroxyl radicals, IC50 = 17.8 µg/mL. • Cytotoxic effects: Growth inhibition observed in Rin-5F and Hep G2 cell lines. • Potential fever reduction: Traditional use in TCM for feverish conditions. • Malaria prevention: Southern China varieties used traditionally to prevent malaria due to higher artemisinin content. • Terpenoid content: Includes key compounds like artemisinin, known for its malaria treatment efficacy.

## Mechanism of Action

Artemisinin's endoperoxide bridge is cleaved by ferrous iron (Fe²⁺) derived from heme in parasitized erythrocytes, generating carbon-centered free radicals that alkylate and damage parasite proteins, including PfATP6 (a sarco-endoplasmic reticulum Ca²⁺-ATPase), disrupting calcium homeostasis and killing Plasmodium parasites. In cancer cell lines, artemisinin and its derivatives activate the intrinsic apoptotic pathway by upregulating Bax, downregulating Bcl-2, and releasing cytochrome c, triggering caspase-3 and caspase-9 activation. The flavonoid and polyphenol fraction of the whole plant contributes [antioxidant activity](/ingredients/condition/antioxidant) via direct hydroxyl radical scavenging, with an IC50 of approximately 17.8 µg/mL in in vitro models.

## Clinical Summary

Artemisinin-based combination therapies (ACTs) have been validated in large-scale randomized controlled trials involving thousands of patients across sub-Saharan Africa and Southeast Asia, demonstrating 95%+ parasite clearance rates for uncomplicated Plasmodium falciparum malaria when artemisinin derivatives are paired with a partner drug such as lumefantrine or mefloquine. In vitro studies on Rin-5F (pancreatic) and HepG2 (hepatocellular carcinoma) cell lines show concentration-dependent growth inhibition, but no large-scale human RCTs support anticancer claims for the whole herb or isolated artemisinin at this time. [Antioxidant](/ingredients/condition/antioxidant) data is limited to cell-free and cell-based assays; no adequately powered human clinical trials have confirmed in vivo antioxidant benefits from Artemisia annua supplementation. Evidence for traditional TCM uses such as fever reduction is largely observational and ethnobotanical, lacking the controlled trial support that the antimalarial application holds.

## Nutritional Profile

Sweet Wormwood (Artemisia annua) is a medicinal herb rather than a dietary staple, so its nutritional profile is characterized primarily by bioactive compounds rather than macronutrients. Dried aerial parts contain approximately 1–3% crude protein, 4–8% crude fiber, and minimal fat content (<1%). Moisture content in fresh herb is approximately 70–80%. Key bioactive compounds include: Artemisinin (sesquiterpene lactone endoperoxide): 0.01–1.5% dry weight depending on chemotype, harvest time, and geographic origin — Southern China varieties reported at the higher end of this range; Artemisinic acid (biosynthetic precursor to artemisinin): 0.4–0.8% dry weight; Dihydroartemisinic acid: 0.2–0.6% dry weight; Flavonoids (total): approximately 1.5–3.5% dry weight, including artemetin, casticin, chrysoplenetin, cirsilineol, and eupatorin — these contribute to the reported IC50 = 17.8 µg/mL hydroxyl radical scavenging activity; Essential oils: 0.1–0.9% by weight, dominated by camphor (up to 30–40% of oil fraction), germacrene D, β-caryophyllene, and α-pinene; Scopoletin (coumarin): trace to 0.02% dry weight; Polyphenolic acids including chlorogenic acid and caffeic acid derivatives at <0.1% dry weight. Mineral content (per 100g dry weight, estimated from comparable Artemisia species): potassium ~900–1200 mg, calcium ~800–1100 mg, magnesium ~150–250 mg, iron ~15–25 mg, zinc ~2–4 mg. Vitamin content is modest: Vitamin C ~20–40 mg/100g fresh weight (heat-labile, degraded in decoctions), Vitamin A precursors (beta-carotene) ~1–3 mg/100g dry weight. Bioavailability notes: Artemisinin has poor and variable oral bioavailability (~30% in humans) due to extensive first-pass [metabolism](/ingredients/condition/weight-management) and its own autoinduction of CYP2B6; fat co-ingestion improves absorption. Flavonoids show moderate bioavailability enhanced by gut microbial metabolism. Traditional aqueous decoctions likely reduce artemisinin content significantly due to its thermal instability above 50°C, meaning cold-press or ethanolic extracts preserve higher concentrations of active sesquiterpenes.

## Dosage & Preparation

No clinically studied dosage ranges for Artemisia annua extracts or powders are available. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Short-term use of artemisinin derivatives at therapeutic antimalarial doses (e.g., artesunate 200 mg/day for 3 days) is generally well-tolerated, but adverse effects can include nausea, vomiting, dizziness, and transient cardiac QTc prolongation, particularly with artemether-lumefantrine combinations. Artemisinin is a potent inducer of CYP2B6 and a moderate inducer of CYP3A4, meaning it can significantly reduce plasma levels of co-administered drugs metabolized by these enzymes, including antiretrovirals, oral contraceptives, and certain anticonvulsants. Neurotoxicity has been observed in animal studies at high doses and with prolonged administration, and while not clearly replicated in standard human therapeutic use, long-term unsupervised supplementation with whole-herb products is not supported by safety data. Artemisia annua is contraindicated in the first trimester of pregnancy due to documented embryotoxicity in animal models, and its use during any stage of pregnancy or lactation should only occur under medical supervision.

## Scientific Research

Current research lacks specific human clinical trials or meta-analyses on Artemisia annua itself. The available evidence primarily focuses on isolated artemisinin for malaria treatment, with no specific PMIDs provided.

## Historical & Cultural Context

In Traditional Chinese Medicine, Artemisia annua, known as Qinghao, has been used for over 2,000 years to treat feverish conditions and to prevent malaria in southern China. Different regional varieties are associated with varying traditional uses due to their differing compound profiles.

## Synergistic Combinations

Ginger, Turmeric, Green Tea, Black Pepper, Ashwagandha

## Frequently Asked Questions

### What is artemisinin and how does it kill malaria parasites?

Artemisinin is a sesquiterpene lactone endoperoxide isolated from Artemisia annua that is activated by heme-derived ferrous iron (Fe²⁺) inside Plasmodium-infected red blood cells. This activation cleaves the endoperoxide bridge to produce cytotoxic free radicals that alkylate parasite proteins, including the calcium pump PfATP6, ultimately killing the parasite within hours. This rapid mechanism of action makes artemisinin derivatives among the fastest-acting antimalarial agents available.

### Can sweet wormwood supplements replace prescription artemisinin for malaria?

No — whole-herb Artemisia annua supplements contain highly variable and generally low concentrations of artemisinin (0.01–1.4% dry weight depending on cultivar and preparation), which is insufficient and unreliable for treating active malaria infections. The WHO explicitly recommends against using non-pharmaceutical Artemisia preparations for malaria treatment due to under-dosing risks that promote artemisinin-resistant Plasmodium strains. Prescription artemisinin-based combination therapies (ACTs) use standardized, pharmaceutical-grade artemisinin derivatives paired with a partner drug to ensure efficacy and reduce resistance risk.

### What are the side effects of taking Artemisia annua supplements?

Common side effects reported with artemisinin and Artemisia annua preparations include gastrointestinal upset (nausea, vomiting, abdominal pain), dizziness, and headache. At high doses or with prolonged use, animal studies have identified neurotoxic effects including brainstem lesions, though this has not been consistently demonstrated in humans at standard therapeutic doses. Cardiac effects such as QTc interval prolongation are a documented concern with certain artemisinin combination formulations, warranting caution in individuals with pre-existing cardiac conditions.

### Does Artemisia annua interact with any medications?

Yes — artemisinin is a potent inducer of CYP2B6 and a moderate inducer of CYP3A4 hepatic enzymes, which means it can accelerate the metabolism and lower blood levels of many medications. Clinically significant interactions include reduced efficacy of HIV antiretrovirals (e.g., efavirenz, lopinavir), oral contraceptives, and antiepileptic drugs such as carbamazepine. Patients taking immunosuppressants, anticoagulants like warfarin, or any narrow therapeutic index drug should consult a physician before using any Artemisia annua product.

### Is there evidence that Artemisia annua has anticancer effects in humans?

Current anticancer evidence for Artemisia annua and its compounds (artemisinin, artesunate, dihydroartemisinin) is primarily preclinical, derived from in vitro studies on cell lines such as HepG2 and Rin-5F and various animal tumor models. Artesunate has been evaluated in a small number of phase I and II clinical trials in colorectal, breast, and non-small-cell lung cancers, showing acceptable safety profiles but only preliminary efficacy signals in very small cohorts (typically under 50 patients). No large-scale RCT has demonstrated statistically significant anticancer benefit in humans, and Artemisia annua supplements should not be used as a substitute for evidence-based cancer therapy.

### What is the difference between sweet wormwood extract and whole plant Artemisia annua supplements?

Sweet wormwood extracts are concentrated forms that isolate artemisinin and other active compounds, typically delivering standardized artemisinin levels (often 0.5–1.5% by weight), while whole plant supplements contain the full spectrum of plant constituents including flavonoids and polyphenols. Extract forms offer more predictable dosing for artemisinin content, whereas whole plant preparations may provide broader phytochemical benefits but with variable active compound concentrations. The choice between them depends on whether you prioritize artemisinin standardization or traditional multi-compound herbal synergy.

### Is sweet wormwood safe to take during pregnancy or while breastfeeding?

Sweet wormwood supplements are not recommended during pregnancy due to potential uterotoxic effects and lack of safety data in human pregnancy studies, though traditional use in some cultures has occurred. Limited evidence exists regarding safety during breastfeeding, and the transfer of artemisinin and other compounds into breast milk has not been thoroughly studied. Pregnant or breastfeeding individuals should consult a healthcare provider before using Artemisia annua supplements.

### What does current clinical research show about sweet wormwood's antioxidant and anticancer potential in humans?

While in vitro studies demonstrate strong antioxidant activity (with IC50 values around 17.8 µg/mL for hydroxyl radical scavenging) and cytotoxic effects in cancer cell lines (Rin-5F and Hep G2), human clinical trials specifically testing these properties remain limited. Most evidence comes from laboratory and animal studies, and results have not yet translated into proven clinical benefit for cancer prevention or treatment in humans. More rigorous human studies are needed before sweet wormwood can be recommended for antioxidant or anticancer purposes outside of its traditional antimalarial use.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*